Carol Holman

ORCID: 0000-0002-5748-9914
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Multiple Myeloma Research and Treatments
  • Viral-associated cancers and disorders
  • Lymphoma Diagnosis and Treatment
  • Peptidase Inhibition and Analysis
  • Cytomegalovirus and herpesvirus research
  • Parvovirus B19 Infection Studies
  • Polyomavirus and related diseases
  • Immune Cell Function and Interaction
  • FOXO transcription factor regulation
  • Protein Degradation and Inhibitors
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Chronic Lymphocytic Leukemia Research
  • Abdominal Trauma and Injuries
  • Cancer Mechanisms and Therapy
  • Long-Term Effects of COVID-19
  • Galectins and Cancer Biology
  • Appendicitis Diagnosis and Management
  • Erythrocyte Function and Pathophysiology
  • Ubiquitin and proteasome pathways
  • Monoclonal and Polyclonal Antibodies Research
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Dermatological and COVID-19 studies
  • Hematological disorders and diagnostics
  • COVID-19 Clinical Research Studies
  • Trauma and Emergency Care Studies

University of Iowa Hospitals and Clinics
2018-2024

University of Iowa
2014-2022

University of Nebraska Medical Center
2020

Riyadh Armed Forces Hospital
2020

Indiana University – Purdue University Indianapolis
2020

Yale University
2020

University of Iowa Holden Comprehensive Cancer Center
2015

University of Minnesota
2009-2012

Twin Cities Orthopedics
2010

University of Washington
2008

Background. Characterizing virus‐host interactions during self‐limited infectious mononucleosis could explain how Epstein‐Barr virus (EBV) replication is normally controlled and provide insight into why certain immunocompromised patients fail to contain it. Methods. University students had an average of 7 clinical virologic evaluations acute mononucleosis. EBV was quantified in 697 samples oral wash fluid, whole blood, peripheral blood mononuclear cells (PBMCs), plasma by a real‐time...

10.1086/491740 article EN The Journal of Infectious Diseases 2005-10-25

Protein-protein interactions are key to function and regulation of many biological pathways. To facilitate characterization protein-protein using mass spectrometry, a new data acquisition/analysis pipeline was designed. The goal for this provide generic strategy identifying cross-linked peptides from single LC/MS/MS sets, without specialized cross-linkers or custom-written software. achieve this, each peptide in the pair considered be "post-translationally" modified with an unknown at amino...

10.1021/ac801646f article EN Analytical Chemistry 2008-10-24

We postulated that quantitative monitoring of Epstein-Barr virus (EBV) shedding after transplantation could distinguish EBV-associated illnesses and predict clinical outcome. EBV DNA was measured in solid organ (SOT) hematopoietic cell transplants (HCT) using our own real-time TaqMan PCR. The proportion patients who had DNAemia post-transplant significantly lower HCT vs. SOT (p < 0.001). Over a 7.5-yr period, lymphoproliferative disorder (PTLD) occurred 66 (5.8%) 1131 met adequate criteria....

10.1111/j.1399-0012.2012.01608.x article EN Clinical Transplantation 2012-03-04

Abstract Acute myeloid leukemia (AML) is maintained by self-renewing leukemic stem cells (LSCs). A fundamental problem in treating AML that conventional therapy fails to eliminate LSCs, which can reinitiate leukemia. Heat shock transcription factor 1 (HSF1), a central regulator of the stress response, has emerged as an important target cancer therapy. Using genetic Hsf1 deletion and direct HSF1 small molecule inhibitor, we show specifically required for maintenance AML, while sparing...

10.1038/s41467-022-33861-1 article EN cc-by Nature Communications 2022-10-16

Wudhikarn K, Holman CJ, Linan M, Blaes AH, Dunitz JM, Hertz ME, Peterson BA. Post‐transplant lymphoproliferative disorders in lung transplant recipients: 20‐yr experience at the University of Minnesota. Clin Transplant 2011: 25: 705–713. © 2010 John Wiley &amp; Sons A/S. Abstract: (PTLD) are potentially fatal complications solid organ transplantation. The natural history PTLD varies considerably among different types organs transplanted. While recipients highly susceptible to PTLD, there...

10.1111/j.1399-0012.2010.01332.x article EN Clinical Transplantation 2010-11-16

Following up on previous work demonstrating the involvement of transcription factor forkhead box M1 (FOXM1) in biology and outcome a high-risk subset newly diagnosed multiple myeloma (nMM), this study evaluated whether FOXM1 gene expression may be further upregulated upon tumor recurrence patients with relapsed (rMM). Also assessed was hypothesis that increased levels diminish sensitivity cells to commonly used drugs, such as proteasome inhibitor bortezomib (Bz) DNA intercalator doxorubicin (Dox).

10.1186/s12885-018-5015-0 article EN cc-by BMC Cancer 2018-11-21

Abstract: A 20‐year‐old patient, who received a bone marrow transplant in order to treat metachromatic leukodystrophy (MLD), succumbed cytomegalovirus (CMV) encephalitis. After CMV viremia developed, the patient ganciclovir, but he was switched foscarnet when ganciclovir resistance suspected. Foscarnet discontinued because of concern about its potential central nervous system toxicity. Autopsy samples brain and cerebrospinal fluid contained DNA with UL97 mutation (M460V) known confer...

10.1034/j.1399-3062.2002.02005.x article EN Transplant Infectious Disease 2002-12-01

KSHV-encoded vIL-6 collaborates with deregulated c-Myc to drive plasmablastic neoplasms in mice

10.1038/bcj.2016.6 article EN cc-by Blood Cancer Journal 2016-02-26

Abstract The cytologic findings of an extranodal NK/T‐cell lymphoma (NKTCL) presenting as a large adrenal mass with leptomeningeal involvement diagnosed by CT‐guided fine‐needle aspiration and cerebrospinal fluid (CSF) cytology are described. 65‐year‐old Caucasian patient presented progressive headache multiple cranial nerve neuropathies. Magnetic resonance imaging showed enhancement surrounding the conus medullaris cauda equine, subsequent PET/CT demonstrated right gland mass. Fine‐needle...

10.1002/dc.21077 article EN Diagnostic Cytopathology 2009-04-16

Lymphomas showing both MYC/8q24 rearrangement and IGH@BCL2/t(14;18)(q32;q21), also referred to as “double‐hit” or “dual‐hit” lymphomas (DHL) are rare B‐cell malignancies with a germinal center immunophenotype heterogeneous cytologic histologic features. Such may arise de novo through transformation of follicular classified either “B‐cell lymphoma, unclassifiable, features intermediate between diffuse large lymphoma (DLBCL) Burkitt (BL)” (most commonly), DLBCL, or, rarely, B‐lymphoblastic...

10.1002/dc.22871 article EN Diagnostic Cytopathology 2012-05-24

Comparative genetic and biological studies on malignant tumor counterparts in human beings laboratory mice may be powerful gene discovery tools for blood cancers, including neoplasms of mature B-lymphocytes plasma cells such as Burkitt lymphoma (BL) multiple myeloma (MM). We used EMSA to detect constitutive NF-κB/STAT3 activity BL- MM-like that spontaneously developed single-transgenic IL6 (interleukin-6) or MYC (c-Myc) mice, double-transgenic IL6MYC mice. qPCR measurements analysis clinical...

10.1186/s40164-015-0005-2 article EN cc-by Experimental Hematology and Oncology 2015-03-27

Follicular helper T cell (TFH) markers are expressed in angioimmunoblastic T-cell lymphoma (AITL) and peripheral of the TFH phenotype (PTCL-TFH). However, differential expression coexpression these benign other malignant lymphoid proliferations have not been well studied.We performed programmed death-1 (PD-1), C-X-C motif chemokine ligand 13 (CXCL13), inducible costimulator (ICOS), CD10, B-cell 6 protein (BCL-6) immunohistochemistry on AITL, PTCL otherwise specified (PTCL-NOS), PTCL-TFH, or...

10.1093/ajcp/aqaa249 article EN American Journal of Clinical Pathology 2020-10-30

Congenital dyserythropoietic anemia (CDA) type‐1 is a rare genetic disorder of ineffective erythropoiesis, which manifests in macrocytic anemia. We report CDA1 patient who as newborn presented with and persistent pulmonary hypertension the (PPHN) requiring mechanical ventilation. Post‐infancy, developed acral dysmorphism pectus excavatum latter rarely found CDA1. Patient compound heterozygote for known maternal‐derived missense‐mutation (c.1796A &gt; G/p.Asn589Ser) novel paternal‐derived...

10.1002/pbc.24945 article EN Pediatric Blood & Cancer 2014-01-13

ABSTRACT We report an instructive case of acute myeloid leukemia with histiocytic differentiation (acute leukemia) arising in a patient, 52-year-old woman history follicular lymphoma. The results genetic studies proved clonal relationship between the lymphoma and leukemic cells. To our knowledge, this is first transdifferentiation into modified base 5-methylcytosine (M5c)–like reported karyotype on transdifferentiated neoplasm.

10.1093/labmed/lmw011 article EN cc-by-nc Laboratory Medicine 2016-04-11

ABSTRACT A semiquantitative PCR assay for the detection of BK virus in urine was developed using primers that specifically amplified but not JC virus. DNA extracted from through treatment with proteinase K followed by precipitation sodium acetate. Semiquantitation achieved amplifying serial dilutions (1:1, 1:10, 1:100, and 1:1,000) specimens. Each included both positive (stock previously patient urine) negative (no template) controls. sample interpreted as if any showed amplification...

10.1128/cdli.10.1.66-69.2003 article EN Clinical and Vaccine Immunology 2003-01-01

Abstract: We developed an in vitro Epstein-Barr virus (EBV) drug susceptibility assay using P3HR1 cells or lymphoblastoid from subjects with infectious mononucleosis, which were grown the presence of various concentrations acyclovir (ACV), ganciclovir (GCV) R-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine (H2G) and 12-O-tetradecanoyl-phorbol-13-acetate (TPA). On day 7, total cellular DNA was extracted EBV detected in-house quantitative real-time polymerase chain reaction (PCR) method. All three...

10.2147/vaat.s8575 article EN Virus Adaptation and Treatment 2010-01-01

Multiparametric flow cytometry is a useful tool for diagnosis of plasma cell (PC) dyscrasias and assessment minimal residual disease in myeloma (PCM). However, the immunophenotypic differences between clonal PCs PCM those monoclonal gammopathy undetermined significance (MGUS) as well correlation these cytometric markers with pertinent laboratory parameters have not been evaluated.We retrospectively identified all newly diagnosed treatment-naive MGUS patients 09/2014 06/2015 who underwent...

10.1002/cyto.b.21624 article EN Cytometry Part B Clinical Cytometry 2018-01-10
Coming Soon ...